Pipeline
PBL201
Allostatine?
- Hybrid Molecule of Human Ig CDR3 and Alloferon
- Interaction of NKG2D receptor
Anti-cancer Effect of Combination Therapy
- Validation of combination tTherapy in orthotopic pancreatic cancer model
- Validation of chemotherapy & aAllostatine combination anti-cancer effect of targeted therapy
- Orthotopic pancreatic cancer Model
-
-
Anti-cancer Effect of Targeted Therapy
- Validation of chemotherapy & allostatine combination in liver mets colon cancer
- Validation of chemotherapy & allostatine combination in orthotopic cancer
- Colon cancer liver metastasis model
-
-
- Ovarian cancer Orthotopic Animal Model
-
-
Patent Application
- Patent Application US Patent Application Priority of pancreatic cancer combination therapy
- Extension of indication in ovarian cancer, colon cancer and any solid Tumor
